Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2015 5
2016 5
2017 1
2018 4
2020 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
How should I treat multiple coronary aneurysms with severe stenoses?
Warisawa T, Naganuma T, Nakamura S, Hartmann M, Stoel MG, Louwerenburg JH, Basalus MW, von Birgelen C, Koo BK. Warisawa T, et al. EuroIntervention. 2015 Nov;11(7):843-6. doi: 10.4244/EIJV11I7A171. EuroIntervention. 2015. PMID: 26603993 Free article. No abstract available.
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
van der Heijden LC, Kok MM, Zocca P, Sen H, Löwik MM, Mariani S, de Man FHAF, Hartmann M, Stoel MG, van Houwelingen KG, Louwerenburg JHW, Linssen GCM, Doggen CJM, Grandjean JG, von Birgelen C. van der Heijden LC, et al. Among authors: louwerenburg jhw. J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212. J Am Heart Assoc. 2018. PMID: 29382666 Free PMC article.
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
von Birgelen C, Kok MM, Sattar N, Zocca P, Doelman C, Kant GD, Löwik MM, van der Heijden LC, Sen H, van Houwelingen KG, Stoel MG, Louwerenburg JHW, Hartmann M, de Man FHAF, Linssen GCM, Doggen CJM, Tandjung K. von Birgelen C, et al. Among authors: louwerenburg jhw. JACC Cardiovasc Interv. 2018 Mar 12;11(5):448-459. doi: 10.1016/j.jcin.2017.10.038. Epub 2018 Feb 14. JACC Cardiovasc Interv. 2018. PMID: 29454724 Free article. Clinical Trial.
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
Zocca P, Kok MM, Tandjung K, Danse PW, Jessurun GAJ, Hautvast RWM, van Houwelingen KG, Stoel MG, Schramm AR, Tjon Joe Gin RM, de Man FHAF, Hartmann M, Louwerenburg JHW, Linssen GCM, Löwik MM, Doggen CJM, von Birgelen C. Zocca P, et al. Among authors: louwerenburg jhw. JACC Cardiovasc Interv. 2018 Mar 12;11(5):462-469. doi: 10.1016/j.jcin.2017.11.031. JACC Cardiovasc Interv. 2018. PMID: 29519378 Free article. Clinical Trial.
Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials.
Kok MM, van der Heijden LC, Sen H, Danse PW, Löwik MM, Anthonio RL, Louwerenburg JH, de Man FH, Linssen GC, IJzerman MJ, Doggen CJ, Maas AH, Mehran R, von Birgelen C. Kok MM, et al. JACC Cardiovasc Interv. 2016 Mar 28;9(6):553-61. doi: 10.1016/j.jcin.2015.10.043. Epub 2016 Mar 2. JACC Cardiovasc Interv. 2016. PMID: 26947384 Free article.
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Zocca P, Kok MM, van der Heijden LC, van Houwelingen KG, Hartmann M, de Man FHAF, Stoel MG, Louwerenburg JHW, Knottnerus IL, Linssen GCM, Doggen CJM, von Birgelen C. Zocca P, et al. Among authors: louwerenburg jhw. Int J Cardiol. 2018 Oct 1;268:11-17. doi: 10.1016/j.ijcard.2018.03.116. Epub 2018 May 23. Int J Cardiol. 2018. PMID: 29801763 Free article. Clinical Trial.
Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.
Huisman J, van der Heijden LC, Kok MM, Louwerenburg JH, Danse PW, Jessurun GA, de Man FH, Löwik MM, Linssen GC, IJzerman MJ, Doggen CJ, von Birgelen C. Huisman J, et al. J Cardiol. 2017 Apr;69(4):660-665. doi: 10.1016/j.jjcc.2016.06.010. Epub 2016 Jul 28. J Cardiol. 2017. PMID: 27476343 Free article.
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial.
Tandjung K, Lam MK, Sen H, de Man FH, Louwerenburg JH, Stoel MG, van Houwelingen KG, Linssen GC, van der Palen J, Doggen CJ, von Birgelen C. Tandjung K, et al. EuroIntervention. 2016 Jul 20;12(4):431-40. doi: 10.4244/EIJY15M08_01. EuroIntervention. 2016. PMID: 26342469 Free article.
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome.
Sen H, Lam MK, Tandjung K, Löwik MM, Stoel MG, de Man FH, Louwerenburg JH, van Houwelingen GK, Linssen GC, Doggen CJ, Basalus MW, von Birgelen C. Sen H, et al. Catheter Cardiovasc Interv. 2015 Jan 1;85(1):74-81. doi: 10.1002/ccd.25464. Epub 2014 Mar 14. Catheter Cardiovasc Interv. 2015. PMID: 24585502 Clinical Trial.
20 results